IART
NASDAQ · Health Care
Integra Lifesciences Holding
$9.31
+0.11 (+1.20%)
Financial Highlights (FY 2026)
Revenue
1.73B
Net Income
-544,959,004
Gross Margin
56.6%
Profit Margin
-31.6%
Rev Growth
+1.6%
D/E Ratio
1.78
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 56.6% | 56.6% | 67.3% | 67.3% |
| Operating Margin | -30.2% | -27.2% | 16.1% | 18.5% |
| Profit Margin | -31.6% | -30.0% | 14.6% | 15.3% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 1.73B | 1.70B | 284.27M | 289.60M |
| Gross Profit | 976.95M | 961.28M | 191.26M | 194.85M |
| Operating Income | -521,947,408 | -462,218,505 | 45.76M | 53.46M |
| Net Income | -544,959,004 | -482,596,776 | 41.42M | 44.34M |
| Gross Margin | 56.6% | 56.6% | 67.3% | 67.3% |
| Operating Margin | -30.2% | -27.2% | 16.1% | 18.5% |
| Profit Margin | -31.6% | -30.0% | 14.6% | 15.3% |
| Rev Growth | +1.6% | +1.6% | +23.9% | +16.2% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 231.49M | 231.49M | 104.07M | 110.88M |
| Total Equity | 130.14M | 130.14M | 274.89M | 305.05M |
| D/E Ratio | 1.78 | 1.78 | 0.38 | 0.36 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | -507,283,285 | -474,189,826 | 83.90M | 77.61M |
| Free Cash Flow | — | — | 47.45M | 57.75M |